Susquehanna International Group, LLP Argenx Se Transaction History

Susquehanna International Group, LLP

$688 Billion
Q2 2025

A detailed history of Susquehanna International Group, LLP transactions in Argenx Se stock. As of the latest transaction made, Susquehanna International Group, LLP holds 23,790 shares of ARGX stock, worth $19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,790

Previous 1,873 1170.15%

Holding current value

$19 Million

Previous $1.11 Million 1083.48%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$532.27 - $656.65 $11.7 Million - $14.4 Million	21,917 Added 1170.15%	23,790 $13.1 Million
Q1 2025 May 14, 2025	BUY	$571.0 - $671.75 $689,197 - $810,802	1,207 Added 181.23%	1,873 $1.11 Million
Q4 2024 Feb 14, 2025	SELL	$520.52 - $638.33 $5.78 Million - $7.09 Million	-11,111 Reduced 94.34%	666 $409,000
Q3 2024 Nov 14, 2024	SELL	$434.22 - $551.9 $3.33 Million - $4.23 Million	-7,670 Reduced 39.44%	11,777 $6.39 Million
Q2 2024 Aug 15, 2024	BUY	$356.01 - $451.55 $6.49 Million - $8.23 Million	18,228 Added 1495.32%	19,447 $8.36 Million
Q1 2024 May 07, 2024	SELL	$356.95 - $413.29 $5.49 Million - $6.36 Million	-15,384 Reduced 92.66%	1,219 $479,000
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $5.63 Million - $8.4 Million	16,603 New	16,603 $6.32 Million
Q1 2023 May 16, 2023	BUY	$334.23 - $403.65 $517,722 - $625,253	1,549 Added 33.62%	6,156 $2.29 Million
Q4 2022 Feb 14, 2023	BUY	$342.17 - $402.31 $1.58 Million - $1.85 Million	4,607 New	4,607 $1.75 Million
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $623,446 - $809,144	2,292 Added 43.77%	7,529 $2.64 Million
Q4 2020 Feb 16, 2021	BUY	$248.13 - $308.36 $843,642 - $1.05 Million	3,400 Added 185.08%	5,237 $1.54 Million
Q2 2020 Aug 14, 2020	SELL	$127.44 - $232.72 $838,555 - $1.53 Million	-6,580 Reduced 78.18%	1,837 $414,000
Q1 2020 May 15, 2020	BUY	$108.83 - $165.23 $124,936 - $189,684	1,148 Added 15.79%	8,417 $1.11 Million
Q3 2019 Nov 14, 2019	SELL	$113.31 - $150.51 $1.28 Million - $1.7 Million	-11,295 Reduced 60.84%	7,269 $828,000
Q2 2019 Aug 16, 2019	BUY	$115.0 - $141.58 $46,000 - $56,632	400 Added 2.2%	18,564 $2.63 Million
Q2 2019 Aug 14, 2019	BUY	$115.0 - $141.58 $1.49 Million - $1.84 Million	12,985 Added 250.72%	18,164 $2.57 Million
Q1 2019 May 15, 2019	BUY	$98.85 - $134.59 $160,730 - $218,843	1,626 Added 45.76%	5,179 $647,000
Q4 2018 Feb 14, 2019	SELL	$63.81 - $109.82 $536,578 - $923,476	-8,409 Reduced 70.3%	3,553 $341,000
Q3 2018 Nov 14, 2018	BUY	$75.5 - $96.63 $903,131 - $1.16 Million	11,962 New	11,962 $907,000

Others Institutions Holding ARGX

# of Institutions

492

Shares Held

28.2M

Call Options Held

370K

Put Options Held

211K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $44.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Argenx Se Transaction History